Skip to main content
Log in

Quantitative assessment of the influence of PPARG P12A polymorphism on gestational diabetes mellitus risk

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

The peroxisome proliferator-activated receptor-γ (PPARG) is a member of the nuclear hormone receptor superfamily that has attracted considerable attention as a candidate gene for gestational diabetes mellitus (GDM) based on its function as a key factor involved in the regulation of adipocyte differentiation as well as lipid and glucose metabolism and insulin sensitivity. Many studies have examined the association between P12A polymorphism (rs1801282) in the PPARG gene and risk of GDM, but the results have been inconsistent. To derive a more precise estimation of the relationship, a meta-analysis of 2,858 GDM patients and 6,890 controls from nine published case–control studies was performed. An overall random effects odds ratio of 0.89 (95 % confidence interval [CI]: 0.77–1.04, P = 0.15) was found for 12A allele. In the subgroup analysis by ethnicity, significantly decreased risks were found in East Asians, while no significant associations were detected among Caucasian and Middle Eastern populations. Similar results were also observed using dominant genetic model. This meta-analysis suggested an overall weak association between the P12A polymorphism and GDM risk among East Asians. However, additional very large-scale studies are warranted to provide conclusive evidence on the effects of the PPARG gene on risk of GDM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Metzger BE, Coustan DR (1998) Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. Diabetes Care 21(Suppl 2):B161–B167

    PubMed  Google Scholar 

  2. Aberg A, Rydhstroem H, Frid A (2001) Impaired glucose tolerance associated with adverse pregnancy outcome: a population-based study in Southern Sweden. Am J Obstet Gynecol 184:77–83

    Article  PubMed  CAS  Google Scholar 

  3. King H (1998) Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care 21(Suppl 2):B9–B13

    PubMed  Google Scholar 

  4. Ferrara A, Kahn HS, Quesenberry CP, Riley C, Hedderson MM (2004) An increase in the incidence of gestational diabetes mellitus: Northern California, 1991–2000. Obstet Gynecol 103:526–533

    Article  PubMed  Google Scholar 

  5. Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS (2005) Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28:579–584

    Article  PubMed  Google Scholar 

  6. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2002

    Article  PubMed  Google Scholar 

  7. Löbner K, Knopff A, Baumgarten A, Mollenhauer U, Marienfeld S, Garrido-Franco M, Bonifacio E, Ziegler AG (2006) Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 55:792–797

    Article  PubMed  Google Scholar 

  8. Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373:1773–1779

    Article  PubMed  CAS  Google Scholar 

  9. Michalik L, Auwerx J, Berger JP et al (2006) International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev 58:726–741

    Article  PubMed  CAS  Google Scholar 

  10. Spiegelman BM (1998) PPAR-c: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507–514

    Article  PubMed  CAS  Google Scholar 

  11. Dubuquoy L, Dharancy S, Nutten S et al (2002) Role of peroxisome proliferator-activated receptor c and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 360:1410–1418

    Article  PubMed  Google Scholar 

  12. Mukherjee R, Jow L, Croston GE et al (1997) Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARc2 versus PPARc1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem 272:8071–8076

    Article  PubMed  CAS  Google Scholar 

  13. Fajas L, Debril MB, Auwerx J (2001) PPAR: an essential role in metabolic control. Nutr Metab Cardiovasc Dis 11:64–69

    PubMed  CAS  Google Scholar 

  14. Deeb SS, Fajas L, Nemoto M et al (1998) A Pro12Ala substitution in PPAR2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284–287

    Article  PubMed  CAS  Google Scholar 

  15. Doney AS, Fischer B, Cecil JE, Boylan K, McGuigan FE, Ralston SH, Morris AD, Palmer CN (2004) Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to type 2 diabetes. Diabetologia 47:555–558

    Article  PubMed  CAS  Google Scholar 

  16. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville J, Deeb S, Auwerx J, Amouyel P (1998) A genetic polymorphism of the peroxisome proliferator-activated receptor gene influences plasma leptin levels in obese humans. Hum Mol Genet 7:435–440

    Article  PubMed  CAS  Google Scholar 

  17. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129

    Article  Google Scholar 

  18. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748

    PubMed  CAS  Google Scholar 

  19. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  PubMed  CAS  Google Scholar 

  20. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629–634

    Article  CAS  Google Scholar 

  21. Heude B, Pelloux V, Forhan A et al (2011) Association of the Pro12Ala and C1431T variants of PPARgamma and their haplotypes with susceptibility to gestational diabetes. J Clin Endocrinol Metab 96:E1656–E1660

    Article  PubMed  CAS  Google Scholar 

  22. Pappa KI, Gazouli M, Economou K et al (2011) Gestational diabetes mellitus shares polymorphisms of genes associated with insulin resistance and type 2 diabetes in the Greek population. Gynecol Endocrinol 27:267–272

    Article  PubMed  CAS  Google Scholar 

  23. Cheng Y, Ma Y, Peng T, Wang J, Lin R, Cheng HD (2010) Genotype discrepancy between maternal and fetal Pro12Ala polymorphism of PPARG2 gene and its association with gestational diabetes mellitus. Zhonghua Fu Chan Ke Za Zhi 45:170–173

    PubMed  CAS  Google Scholar 

  24. Cho YM, Kim TH, Lim S et al (2009) Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia 52:253–261

    Article  PubMed  CAS  Google Scholar 

  25. Zhu Y, Wu Y (2009) Relationship between Prol2Ala polymorphism in peroxisome proliferators-activated receptor gamma 2 gene and gestational diabetes mellitus. Shi Yong Yi Xue Za Zhi 25:1963–1965 (in Chinese)

    CAS  Google Scholar 

  26. Lauenborg J, Grarup N, Damm P et al (2009) Common type 2 diabetes risk gene variants associate with gestational diabetes. J Clin Endocrinol Metab 94:145–150

    Article  PubMed  CAS  Google Scholar 

  27. Shaat N, Lernmark A, Karlsson E et al (2007) A variant in the transcription factor 7-like 2 (TCF7L2) gene is associated with an increased risk of gestational diabetes mellitus. Diabetologia 50:972–979

    Article  PubMed  CAS  Google Scholar 

  28. Tok EC, Ertunc D, Bilgin O, Erdal EM, Kaplanoglu M, Dilek S (2006) PPAR-gamma2 Pro12Ala polymorphism is associated with weight gain in women with gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 129:25–30

    Article  PubMed  CAS  Google Scholar 

  29. Shaat N, Ekelund M, Lernmark A et al (2004) Genotypic and phenotypic differences between Arabian and Scandinavian women with gestational diabetes mellitus. Diabetologia 47:878–884

    Article  PubMed  CAS  Google Scholar 

  30. Altshuler D, Hirschhorn JN, Klannemark M et al (2000) The common PPAR Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76–80

    Article  PubMed  CAS  Google Scholar 

  31. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177–182

    Article  PubMed  CAS  Google Scholar 

  32. Tönjes A, Scholz M, Loeffler M, Stumvoll M (2006) Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor with pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care 29:2489–2497

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiaotian Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, C., Li, X., Huang, Z. et al. Quantitative assessment of the influence of PPARG P12A polymorphism on gestational diabetes mellitus risk. Mol Biol Rep 40, 811–817 (2013). https://doi.org/10.1007/s11033-012-2119-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-2119-5

Keywords

Navigation